Zafirlukast
生产企业:Astrazeneca uk ltd
Zafirlukast is a leukotriene receptor antagonist used for prophylaxis and chronic treatment of asthma.
Zafirlukast is a leukotriene receptor antagonist used for prophylaxis and chronic treatment of asthma.
Zafirlukast is a selective and competitive receptor antagonist of leukotriene D4 and E4 (LTD and LTE4), components of slow-reacting substance of anaphylaxis (SRSA). Cysteinyl leukotriene production and receptor occupation have been correlated with the pathophysiology of asthma, including airway edema, smooth muscle constriction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.
For the prophylaxis and chronic treatment of asthma.
共 2 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。